Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus (Q28368057)
Jump to navigation
Jump to search
scientific article published on December 1, 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus |
scientific article published on December 1, 1994 |
Statements
Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus (English)
0 references
L. W. Frick
C. U. Lambe
L. St John
L. C. Taylor
December 1994
0 references
38
0 references
12
0 references
2722-9
0 references
1 reference